3 Reasons to Buy Moderna Stock
Although (NASDAQ: MRNA) is now a somewhat famous biotech, it was a relatively unknown, clinical-stage company just five years ago. Its success in the COVID-19 vaccine market catapulted it to new heights.
However, once the pandemic began subsiding, with a substantial decline in coronavirus-related sales, Moderna's shares suffered. They're down by 25% over the past three years. Is Moderna just a pandemic stock?
Not at all. Let's consider three reasons why investing in the company today is worth it.
Source Fool.com
Moderna Inc. Stock
The stock is one of the favorites of our community with 25 Buy predictions and 4 Sell predictions.
With a target price of 124 € there is potential for a 126.11% increase which would mean more than doubling the current price of 54.84 € for Moderna Inc..